(Reuters) - Jordan's Hikma Pharmaceuticals said on Wednesday it was entering the Ethiopian market through a joint venture with Sheikh Mohammed Hussein Al Amoudi's MIDROC Group.
London-listed Hikma said the joint venture, named HikmaCure, would establish an Ethiopian operating company, build a local manufacturing facility and would begin marketing and distributing pharmaceutical products in Ethiopia.
The two groups will provide up to $22.3 million each to the joint venture, Hikma said in a statement.
http://www.reuters.com
London-listed Hikma said the joint venture, named HikmaCure, would establish an Ethiopian operating company, build a local manufacturing facility and would begin marketing and distributing pharmaceutical products in Ethiopia.
The two groups will provide up to $22.3 million each to the joint venture, Hikma said in a statement.
http://www.reuters.com
Chirurgie esthetique Nice
ReplyDelete